Name | VRX-0466617 |
---|---|
Synonyms |
5-({4-[(4-bromophenyl)amino]phenyl}amino)-3-hydroxy-N-(1-hydroxypropan-2-yl)-1,2-thiazole-4-carboximidamide
4-Isothiazolecarboximidamide, 5-[[4-[(4-bromophenyl)amino]phenyl]amino]-2,3-dihydro-N-(2-hydroxy-1-methylethyl)-3-oxo- 5-({4-[(4-Bromophenyl)amino]phenyl}amino)-N-(1-hydroxy-2-propanyl)-3-oxo-2,3-dihydro-1,2-thiazole-4-carboximidamide |
Description | VRX0466617, a selective Chk2 inhibitor, inhibits the phosphorylation of Chk2 Ser 19 and Ser33-35. VRX0466617 can be used in the study of cancer[1]. |
---|---|
Related Catalog | |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 545.4±60.0 °C at 760 mmHg |
Molecular Formula | C19H20BrN5O2S |
Molecular Weight | 462.36 |
Flash Point | 283.6±32.9 °C |
Exact Mass | 461.052094 |
LogP | 3.06 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.714 |
Storage condition | store at -20℃ for one year(Powder) |